Predicting Postoperative Liver Dysfunction in Patuents with HBV-HCC Based on Blood Derived MicroRNA Signatures

Comprehensive prediction of postoperative hepatic insufficiency in patients with hepatocellular carcinoma associated with hepatitis b

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR1900022599

Enrollment

Unknown

Registered

2019-04-18

Start date

2019-06-01

Completion date

Unknown

Last updated

2019-04-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

hepatitis B virus (HBV)-related hepatocellular carcinoma (HCC)

Interventions

hepatic dysfunction group+ non-dysfunction group:No Intervention

Eligibility

Sex/Gender

All

Age

18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Hepatitis b related liver cancer patients; 2. Cases treated with hepatectomy and confirmed by postoperative pathological examination as primary liver cancer (PLC); 3. Indocyanogen green excretion test was performed preoperatively. 4. Preoperative CT examination; No obvious cardiopulmonary disease. 5. Good general condition.

Exclusion criteria

Exclusion criteria: 1. Preoperative biochemical examination indicated obstructive jaundice; 2. Those who have received preoperative chemoradiotherapy or interventional therapy.

Design outcomes

Primary

Measure	Time frame
postoperative liver dysfunction;	—

Countries

China

Contacts

Public ContactSongqing He

Department of Hepatobiliary and Pancreatic Surgery, the First Affiliated Hospital of Guangxi Medical University

dr_hesongqing@163.com+86 0773 5356568

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026